Acorda Therapeutics reported $28.68M in Stock for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 14.34M 3.55M
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
ALKERMES ALKS:US $ 138.7M 2.62M
Amgen AMGN:US $ 4152M 37M
Biogen BIIB:US $ 1347.9M 93.1M
Biomarin Pharmaceutical BMRN:US $ 749.41M 38.43M
Clovis Oncology CLVS:US $ 17.28M 7.72M
Gilead Sciences GILD:US $ 2797M 191M
GlaxoSmithKline GSK:LN 6244M 86M
Halozyme Therapeutics HALO:US $ 55.98M 2.58M
Heron Therapeutics HRTX:US $ 41.5M 1.3M
Ligand Pharmaceuticals LGND:US $ 33M 6.95M
Mannkind MNKD:US $ 7.48M 0M
Merck MRK:GR € 3760M 196M
Neurocrine Biosciences NBIX:US $ 25.5M 2.8M
Novartis NOVN:VX SF 6885M 226M
Teva Pharmaceutical TEVA:IT 4.17B 195M
Ultragenyx Pharmaceutical RARE:US $ 15.19M 0.11M
Vertex Pharmaceuticals VRTX:US $ 333.46M 11.84M